Chairman of the Egyptian Drug Authority Reviews Pharmaceutical Sector Development Plans Through 2030
Dr. Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority, participated in the fifth edition of the Africa Health ExCon 2026. This conference is considered one of the most significant medical events on the African continent, aiming to enhance health cooperation and the exchange of expertise between various countries.
During his speech at the conference, the Chairman reviewed the major achievements made by the pharmaceutical sector in Egypt over the past years. He noted that the Egyptian state is working hard to provide high-quality medicines and medical supplies at affordable prices for citizens, reinforcing Egypt's position as a leading regional hub in the pharmaceutical industry.
Dr. El-Ghamrawy discussed the future development plans adopted by the Authority through 2030. These plans aim to increase local production of medicines and reduce reliance on imports. Additionally, the Authority seeks to support innovation and scientific research in the field of modern medicines to address evolving health challenges.
The Chairman emphasized the importance of cooperation with African nations in the field of healthcare. He explained that Egypt is ready to transfer its expertise and successful experiences in regulating the pharmaceutical market to its counterparts in Africa, helping to improve medical service standards and provide treatment for all African peoples.
In conclusion, this conference represents an important step toward achieving sustainable development in the Egyptian and African health sectors. These efforts are expected to contribute to building a resilient health system capable of facing crises, ensuring a better, healthier life for citizens in the future.